Nova Biomedical has received FDA clearance for a micro capillary sample mode on the Stat Profile Prime Plus Critical Care analyzer. This mode allows for an 11-test panel with just 90 microliters of blood, or a 22-test panel with 135 microliters. The analyzer provides a range of critical care tests with minimal blood volume, reducing the need for blood products and potentially improving patient outcomes. The analyzer’s technology also eliminates sample waste and allows for scheduled bundling of tests. This innovation in blood conservation and comprehensive testing is a significant advancement in critical care diagnostics.
Source link
FDA clears Nova’s Stat Profile Prime Plus analyzer for micro capillary sample mode
